High corn oil and extra virgin olive oil diets and experimental mammary carcinogenesis: clinicopathological and immunohistochemical p21Ha-Ras expression study.
Dietary lipids have a role in the aetiology of breast cancer, acting at several cellular levels. We investigated the effects of a high corn oil and a high extra virgin olive oil diet on the clinical and histopathological characteristics of rat dimethylbenz(α)anthracene-induced mammary carcinogenesis and on the expression of p21Ha-Ras, detected by immunohistochemistry, in one experimental series including a low-fat corn oil diet (LFCO) and two high-fat diet groups: HFCO(P), rich in corn oil, and HFOO(P), rich in extra virgin olive oil. Whereas the high corn oil diet tended to reduce latency time, to raise tumour incidence and to increase total tumour yield, the high extra virgin olive oil diet led to a latency time similar to that of LFCO and to a lower tumour incidence than HFCO(P) and lower total tumour yield, even than LFCO. HFCO(P) tumours displayed a higher histological grade and profile than LFCO tumours, while adenocarcinomas in HFOO(P) were similar to LFCO ones. Although no significant differences in p21Ha-Ras expression among dietary groups was found, we detected a significant p21Ha-Ras decreasing expression as grade increased, in groups LFCO and HFCO(P). HFOO(P) tumours exhibited a higher staining in high-grade carcinomas compared to the similar malignant tumours of the two other dietary groups. These data suggest that dietary lipids influence the clinical behaviour and the morphological malignancy of the experimental mammary carcinogenesis, according to the type of fat, without altering p21Ha-Ras expression. Nevertheless, this expression could be affected by the malignancy of tumours, probably through a post-translational event.
Department of Cell Biology, Physiology and Immunology, Medical Physiology Unit, Medical School, Universitat Autònoma de Barcelona, 08193, Bellaterra, Barcelona, Spain.
Irmgard
I
Costa
Raquel
R
Moral
Montserrat
M
Solanas
Francisco Javier
FJ
Andreu
Maria Carmen
MC
Ruiz de Villa
Eduard
E
Escrich
D000818:Animals; D003314:Corn Oil / Q000494:pharmacology*; D004032:Diet; D005260:Female; D007150:Immunohistochemistry; D008325:Mammary Neoplasms, Experimental / Q000378:metabolism* / Q000473:pathology*; D000069463:Olive Oil; D010938:Plant Oils / Q000494:pharmacology*; D016283:Proto-Oncogene Proteins p21(ras) / Q000096:biosynthesis*; D051381:Rats; D017207:Rats, Sprague-Dawley
D000069463:Olive Oil; D010938:Plant Oils; D003314:Corn Oil; D016283:Proto-Oncogene Proteins p21(ras)
Oncol Rep. 2003 Sep-Oct;10(5):1417-24
12883717
Int J Epidemiol. 2006 Aug;35(4):1011-21
16672309
In Vivo. 1994 Mar-Apr;8(2):183-9
7919121
Nat Rev Mol Cell Biol. 2008 Jul;9(7):517-31
18568040
Mol Carcinog. 2002 Apr;33(4):219-27
11933075
Nutr Cancer. 1998;31(3):160-7
9795967
Histopathology. 1991 Nov;19(5):403-10
1757079
Am J Clin Nutr. 1997 Dec;66(6 Suppl):1523S-1529S
9394710
In Vivo. 1994 Nov-Dec;8(6):1099-105
7772745
Am J Physiol Cell Physiol. 2001 May;280(5):C1066-75
11287318
Clin Transl Oncol. 2006 Dec;8(12):868-83
17169760
Biochem Biophys Res Commun. 1998 Oct 20;251(2):609-12
9792821
Mol Nutr Food Res. 2007 Oct;51(10):1279-92
17879998
Am J Med. 2002 Dec 30;113 Suppl 9B:63S-70S
12566141
Int J Biol Markers. 1987 Sep-Dec;2(3):197-206
3131452
Carcinogenesis. 2005 Apr;26(4):763-9
15637090
Anticancer Res. 1997 Jan-Feb;17(1A):349-56
9066676
Cancer Res. 1997 Jan 15;57(2):253-8
9000564
Annu Rev Nutr. 2000;20:221-48
10940333
Carcinogenesis. 1999 May;20(5):785-91
10334194
Nat Rev Cancer. 2003 Jun;3(6):459-65
12778136
Oncol Rep. 2001 Mar-Apr;8(2):435-9
11182070
Ann Surg. 1961 Dec;154(6)Suppl:315-8
14449779
Cancer Lett. 1987 Jun;35(3):281-94
3036343
Int J Oncol. 2002 Feb;20(2):273-7
11788888
Int J Oncol. 2002 Oct;21(4):745-53
12239612
Arch Pathol Lab Med. 2002 Aug;126(8):915-27
12171489
Int J Biochem Cell Biol. 2008;40(12):2707-19
18562239
Prog Lipid Res. 1999 May;38(3):261-71
10664796
Acta Cytol. 1994 May-Jun;38(3):335-40
8191822
Oncology. 1986;43(1):36-9
2417178
Am J Clin Nutr. 1997 Dec;66(6 Suppl):1513S-1522S
9394709
Carcinogenesis. 2010 May;31(5):871-9
19825967
J Mammary Gland Biol Neoplasia. 2001 Jan;6(1):101-13
11467446
Cancer Epidemiol Biomarkers Prev. 2000 Sep;9(9):869-73
11008902
J Nutr Biochem. 2001 Sep;12(9):536-549
11834214
Breast Cancer Res Treat. 2004 Aug;86(3):225-35
15567939
Mol Carcinog. 2004 Jun;40(2):73-8
15170812
In Vivo. 1994 Nov-Dec;8(6):1107-11
7772746
Int J Biol Markers. 1992 Jan-Mar;7(1):35-42
1349907
Carcinogenesis. 2005 Feb;26(2):503-9
15528215
Mol Carcinog. 1997 Dec;20(4):348-54
9433479
CA Cancer J Clin. 2008 Mar-Apr;58(2):71-96
18287387
Int J Mol Med. 2004 Aug;14(2):283-7
15254779
Oncol Rep. 2008 Aug;20(2):429-35
18636208
Eur J Cancer Prev. 2009 Apr;18(2):153-61
19337063
J Pathol. 1988 Oct;156(2):147-53
3058913
Cancer Res. 1987 Sep 15;47(18):4905-8
3621183
Tumour Biol. 1999 Jul-Aug;20(4):173-83
10393527
Breast Cancer Res Treat. 1991 Jan-Feb;17(3):161-9
2039838
Carcinogenesis. 1999 Dec;20(12):2209-18
10590211
Br J Cancer. 1992 Jan;65(1):45-50
1733441
Appl Immunohistochem Mol Morphol. 2000 Mar;8(1):12-8
10937043
Anticancer Res. 1997 Jan-Feb;17(1A):197-203
9066651